Literature DB >> 7756735

Assessment of blood-retinal barrier integrity.

S A Vinores1.   

Abstract

The blood-retinal barrier consists of two components which are comprised of the retinal vascular endothelium and the retinal pigment epithelium, respectively. Its functional integrity can be recognized by tight junctions between these cells with a paucity of endocytic vesicles within them and the presence of the molecules that regulate the ionic and metabolic gradients that constitute the barrier. The barrier is compromised in several disease processes and by a variety of agents, but in most cases the location and mechanism for barrier failure is not understood. Perfusion with a variety of radiolabeled tracer molecules, vitreous fluorophotometry, or magnetic resonance imaging can be used to quantitate blood-retinal barrier leakage. Fluorescein angiography or magnetic resonance imaging can localize sites of leakage in vivo with limited resolution. Evans blue dye can be used to visualize blood-retinal barrier failure in gross pathological specimens and immuno-histochemical labeling of serum proteins such as albumin or fibrinogen can be used to localize sites of blood-retinal barrier breakdown by light microscopy. Tracers such as horseradish peroxidase, microperoxidase, or lanthanum, or the immunocytochemical demonstration of albumin can be used to reveal blood-retinal barrier breakdown at the ultrastructural level and provide insights into the mechanisms involved. This review discusses the advantages and limitations of each of these methods to aid in selection of the appropriate techniques to derive the desired information.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7756735

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  20 in total

1.  Labelling of retinal microglial cells following an intravenous injection of a fluorescent dye into rats of different ages.

Authors:  X X Zeng; Y K Ng; E A Ling
Journal:  J Anat       Date:  2000-02       Impact factor: 2.610

2.  Assessing the effects of ketorolac and acetazolamide on macular thickness by optical coherence tomography following cataract surgery.

Authors:  Ece Turan-Vural; Elvin Halili; Didem Serin
Journal:  Int Ophthalmol       Date:  2014-06       Impact factor: 2.031

3.  Differential permeability of blood microvasculatures in various sympathetic ganglia of rodents.

Authors:  Y P Chau; K S Lu
Journal:  Anat Embryol (Berl)       Date:  1996-09

4.  Pazopanib, a multitargeted tyrosine kinase inhibitor, reduces diabetic retinal vascular leukostasis and leakage.

Authors:  Ashish Thakur; Robert I Scheinman; Vidhya R Rao; Uday B Kompella
Journal:  Microvasc Res       Date:  2011-09-16       Impact factor: 3.514

5.  Single periocular injection of celecoxib-PLGA microparticles inhibits diabetes-induced elevations in retinal PGE2, VEGF, and vascular leakage.

Authors:  Aniruddha C Amrite; Surya P Ayalasomayajula; Narayan P S Cheruvu; Uday B Kompella
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-03       Impact factor: 4.799

6.  Anatomical, blood oxygenation level-dependent, and blood flow MRI of nonhuman primate (baboon) retina.

Authors:  Yi Zhang; Hsiao-Ying Wey; Oscar San Emeterio Nateras; Qi Peng; Bryan H De La Garza; Timothy Q Duong
Journal:  Magn Reson Med       Date:  2011-02-28       Impact factor: 4.668

Review 7.  Magnetic resonance imaging of the retina.

Authors:  Timothy Q Duong; Eric R Muir
Journal:  Jpn J Ophthalmol       Date:  2009-09-08       Impact factor: 2.447

8.  Magnetic resonance imaging of the retina: A brief historical and future perspective.

Authors:  Timothy Q Duong
Journal:  Saudi J Ophthalmol       Date:  2011-01-26

Review 9.  Layer-specific anatomical, physiological and functional MRI of the retina.

Authors:  Timothy Q Duong; Machelle T Pardue; Peter M Thulé; Darin E Olson; Haiying Cheng; Govind Nair; Yingxia Li; Moon Kim; Xiaodong Zhang; Qiang Shen
Journal:  NMR Biomed       Date:  2008-11       Impact factor: 4.044

10.  Intravitreal triamcinolone acetonide inhibits breakdown of the blood-retinal barrier through differential regulation of VEGF-A and its receptors in early diabetic rat retinas.

Authors:  Xinyuan Zhang; Shisan Bao; Donna Lai; Robert W Rapkins; Mark C Gillies
Journal:  Diabetes       Date:  2008-01-03       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.